Supplementary material to : A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classic factors and breast density

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Randomised controlled trial of breast cancer and multiple disease prevention weight loss programmes vs written advice amongst women attending a breast cancer family history clinic

  2023cites this paper
• Genetic architecture of mammographic density as a risk factor for breast cancer: a systematic review

  2023cites this paper
• Polygenic risk scores and breast cancer risk prediction

  2023influential citation
• A Systematic Review and Critical Assessment of Breast Cancer Risk Prediction Tools Incorporating a Polygenic Risk Score for the General Population

  2023influential citation
• Overall survival of breast cancer patients in association with ESR1 polymorphism

  2023cites this paper
• A Breast Cancer Polygenic Risk Score Is Feasible for Risk Stratification in the Norwegian Population

  2023cites this paper
• Evaluation of an AI Model to Assess Future Breast Cancer Risk.

  2023cites this paper
• Estimating the Cost of 3 Risk Prediction Strategies for Potential Use in the United Kingdom National Breast Screening Program

  2023cites this paper
• Detection of IL-1β, VEGF and IL-4 with Their Novel Genetic Variations in Breast Cancer Patients

  2022cites this paper
• Detection of IL-1β, VEGF and IL-4 with their novel genetic variations in breast cancer patients

  2022cites this paper
• Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel.

  2022cites this paper
• What are the reasons to use the Gail risk assessment model?

  2022cites this paper
• Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease.

  2022cites this paper
• Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study

  2022cites this paper
• Polygenic risk scores: the future of cancer risk prediction, screening, and precision prevention

  2021cites this paper
• Assessing Risk of Breast Cancer: A Review of Risk Prediction Models.

  2021cites this paper
• From BRCA1 to Polygenic Risk Scores: Mutation-Associated Risks in Breast Cancer-Related Genes

  2021cites this paper
• Prospective Evaluation of the Addition of Polygenic Risk Scores to Breast Cancer Risk Models

  2021cites this paper
• Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing

  2021influential citation
• Performance of the IBIS/Tyrer‐Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative

  2021cites this paper
• The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?

  2021cites this paper
• Can the epigenome contribute to risk stratification for cancer onset?

  2021cites this paper
• Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women

  2021cites this paper
• Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry

  2021cites this paper
• Long-Term Evaluation of Women Referred to a Breast Cancer Family History Clinic (Manchester UK 1987–2020)

  2020cites this paper
• Simplified Breast Risk Tool Integrating Questionnaire Risk Factors, Mammographic Density, and Polygenic Risk Score: Development and Validation

  2020cites this paper
• Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry

  2020cites this paper
• Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

  2020cites this paper
• Breast Cancer Risk Based on Adapted IBIS Prediction Model in Slovenian Women Aged 40–49 Years - Could it be Better?

  2020cites this paper
• Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes

  2020cites this paper
• Key steps for effective breast cancer prevention

  2020cites this paper
• The introduction of risk stratified screening into the NHS breast screening Programme: views from British-Pakistani women

  2020cites this paper
• Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort

  2020cites this paper
• Breast cancer prevention in high-risk women.

  2019cites this paper